Edaravone Dexborneol Sublingual Tablet

edaravone dexborneol · Simcere Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Edaravone Dexborneol Sublingual Tablet, covering 2025-09-03 to 2025-09-03. Get the full timeline:

Most recent: Clinical Trial Update: Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients [Phase 2]